UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000021195 |
|---|---|
| Receipt number | R000024444 |
| Scientific Title | efficacy and adverse events in 2 different SLIT tablets for house dust mite allergy |
| Date of disclosure of the study information | 2017/04/01 |
| Last modified on | 2018/10/11 11:28:46 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
efficacy and adverse events in 2 different SLIT tablets for house dust mite allergy
Acronym
efficacy and safety in SLIT tablets
Scientific Title
efficacy and adverse events in 2 different SLIT tablets for house dust mite allergy
Scientific Title:Acronym
efficacy and safety in SLIT tablets
Region
| Japan |
Condition
Condition
house dust mite - nasal allergy
Classification by specialty
| Clinical immunology | Oto-rhino-laryngology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To compare efficacy and safety in 2 different SLIT (sublingual immunotherapy)tablets
Basic objectives2
Others
Basic objectives -Others
novel allergen sensitization
asthma prevalence
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
nasal symptom score, medication score, symptom-medication score, QOL, adverse events
Key secondary outcomes
process of HDM sepecific IgE, IgG4 during and after SLIT
novel allergen sensitaization, asthma prevalence rate after SLIT
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
3
Purpose of intervention
Treatment
Type of intervention
| Medicine |
Interventions/Control_1
actair treatment group
Interventions/Control_2
miticure treatment group
Interventions/Control_3
control
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 12 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
house-dust-mite allergic rhinitis
Key exclusion criteria
pregnant at the start of treatment
patients who suffered from malignancy and/or connective tissue disase
patinents who have uncontrolled athma
patients who have severe heart diseases or stroke
patients who are prescribed beta-antatonisit
patnets who are prescribed oral steroid (5mg>=)
Target sample size
80
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Atsushi Kamijo |
Organization
Saitama Medical University
Division name
otorhinolaryngology
Zip code
Address
38 Morohongo, Moroyama-machi, Iruma-gun, Saitama, Japan
TEL
049-276-1253
atkamijo@saitama-med.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Atsushi Kamijo |
Organization
Saitama Medical University
Division name
Otorhinolaryngology
Zip code
Address
38 Morohongo, Moroyama-machi, Iruma-gun, Saitama, Japan
TEL
049-276-1253
Homepage URL
atkamijo@saitama-med.ac.jp
Sponsor or person
Institute
Otorhinolaryngology, Saitama Medical University
Institute
Department
Personal name
Funding Source
Organization
Otorhinolaryngology, Saitama Medical University
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2017 | Year | 04 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Terminated
Date of protocol fixation
| 2017 | Year | 03 | Month | 24 | Day |
Date of IRB
Anticipated trial start date
| 2017 | Year | 04 | Month | 01 | Day |
Last follow-up date
| 2031 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2016 | Year | 02 | Month | 25 | Day |
Last modified on
| 2018 | Year | 10 | Month | 11 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024444
